Intercept Pharmaceuticals Cuts 146 Jobs After Drug Safety Concerns
SOURCENews reportView the filing ↗
What we know
Location: New Jersey, USA.
Based on news reporting.
Summary
Intercept Pharmaceuticals has laid off 146 employees following safety concerns related to one of its drugs, which was linked to several deaths. The layoffs are part of a broader response to the challenges the company faces in ensuring drug safety and maintaining operational efficiency. This decision reflects the company's commitment to addressing these serious issues while navigating the complexities of the pharmaceutical industry. The layoffs took effect in early October 2023, impacting the workforce in New Jersey.
Intercept Pharmaceuticals cut 146 jobs in NJ as of December 17, 2025.
That is roughly 73% of the 200 people Intercept Pharmaceuticals employs.
LayoffTalk has tracked 3 layoff events at Intercept Pharmaceuticals since December 2025, including 146 jobs documented in official WARN filings, with 2 additional events known from news reporting.
Comments (0)
Anonymous by default. Be kind — people reading this may be going through it right now.
No comments yet. Be the first to share your thoughts.
Affected by this?
Share your story anonymously — it helps others reading this feel less alone.
Share your story →More layoffs at Intercept Pharmaceuticals
Recent tracked events at this company.
Recent layoffs in NJ
Other companies with tracked events in the same state.